EUVIMEDOpdag EUVIMED
Crossref

One-year clinical results with actarit—a preliminary report

Hiroshi Takahashi, Shoji Uchida, Yoshiaki Kuga, Michinobu Koda, Nobuyuki Suzuki, Shin’ichi Yoshino

Japanese Journal of Rheumatology · 1998

DOI: 10.1007/bf03041254 ↗

At a glance

Journal article in Japanese Journal of Rheumatology, 1998. Written by Hiroshi Takahashi and 5 co-authors. 5 references.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The effectiveness and safety of 1-year treatment with actarit were evaluated in patients with rheumatoid arthritis. Treatment was continued for 1 year or longer in 18 of the 34 patients. Early improvement in morning stiffness, grip strength, joint score and the Lansbury’s index were observed. Improvement in 1-h eythrocyte sedimentation rate was observed at the 12-month assessment. IgG was decreased at the 12-month assessment. Obvious improvement in C-reactive protein was not seen through the trial. No abnormal findings were noted in routine blood tests. Adverse reactions of special note were skin eruption in one patient and digestive symptom in one patient. However, no serious adverse reactions were observed.

Cite

APA

Takahashi, H., Uchida, S., Kuga, Y., Koda, M., Suzuki, N., & Yoshino, S. (1998). One-year clinical results with actarit—a preliminary report. Japanese Journal of Rheumatology. https://doi.org/10.1007/bf03041254

Vancouver

Takahashi H, Uchida S, Kuga Y, Koda M, Suzuki N, Yoshino S. One-year clinical results with actarit—a preliminary report. Japanese Journal of Rheumatology. 1998. doi:10.1007/bf03041254

BibTeX
@article{Takahashi1998,
  author = {Takahashi, Hiroshi and Uchida, Shoji and Kuga, Yoshiaki and Koda, Michinobu and Suzuki, Nobuyuki and Yoshino, Shin’ichi},
  title = {One-year clinical results with actarit—a preliminary report},
  journal = {Japanese Journal of Rheumatology},
  year = {1998},
  doi = {10.1007/bf03041254}
}
Start for free →